NanoBiotechnology Laboratory

As historic MDMA decision nears, even J.P. Morgan eyes psychedelic investments fiercebiotech.com/biotech/jp-mor…

Longboard’s shares triple as epilepsy med halves seizure rates in early-stage trial fiercebiotech.com/biotech/longbo…

Wishing everyone a wonderful festive season, fortunate to work and collaborate with such amazing people everyday, all the best for 2024.

Scalable human embryo model displays earliest stages of blood cell production fiercebiotech.com/research/scala…

UPDATE: Roche muscles in on obesity market with $2.7B Carmot buyout, securing injectable and oral assets fiercebiotech.com/biotech/roche-…

AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field fiercepharma.com/pharma/abbvie-…

Just over a week until the VBIC Annual Network Meeting! Don't miss out on this opportunity to hear about the latest innovations in imaging research, as well as industry and commercialisation insights! Secure your spot now- eventbrite.com.au/e/691502120457

We are only 3 weeks away from the VBIC Annual Network Meeting!! Be sure to seize this opportunity to join fellow researchers and industry partners in Victoria's imaging community. Register now to secure your spot: eventbrite.com.au/e/victoria-bio…

ESMO: As peers enter radiopharmaceuticals, Novartis says welcome to the party fiercebiotech.com/biotech/esmo-p…

Roche's BTK inhibitor may have reached 'holy grail' of brain penetration in phase 2 MS trial fiercebiotech.com/biotech/roches…

Incidental CAC missed in CT chest scans: study: thelimbic.com/cardiology/inc…

Novartis targets first-line use for radiotherapy Lutathera after trial win in neuroendocrine tumors fiercepharma.com/pharma/novarti…

'Quantum therapeutic' triggers glioblastoma cells to self-destruct fiercebiotech.com/research/quant…

Blackstone's $250M bet beats Xarelto in bleeding trial, making case for Anthos' ex-Novartis asset fiercebiotech.com/biotech/blacks…

No more needles, an oral insulin medication could be on the horizon - Advanced Science News advancedsciencenews.com/no-more-needle…

Eli Lilly hops aboard for Mariana Oncology's $175M series B, radiopharmaceuticals mission fiercebiotech.com/biotech/eli-li…

Australian R&D spending drops as percentage of GDP shar.es/agn3nI

RayzeBio plans IPO to push radiotherapy 'pipeline-in-a-product' through phase 3 fiercebiotech.com/biotech/rayzeb…

cendigitalmagazine.acs.org/2023/08/11/cen…?

Johns Hopkins makes major investment in the power, promise of data science and artificial intelligence bit.ly/3Ksp0Nz via @HubJHU